| 資料 |
タイトル |
|
| 論文 |
Disease progression and pharmacological intervention in a nutrient-deficient rat model of nonalcoholic steatohepatitis. Tølbøl et al. Digestive Diseases and Sciences 64(5):1238-1256, 2019. |
閲覧 |
| レビュー |
Animal Models of Type 2 Diabetes, Obesity and Nonalcoholic Steatohepatitis – Clinical Translatability and Applicability in Preclinical Drug Development. Hansen et al. (2019). |
閲覧 |
| ポスター |
The autotaxin inhibitor BLD-0409 improves disease hallmarks in the CDAA-HFD-induced non-obese and biopsy-confirmed rat model of NASH with progressive fibrosis. |
閲覧 |
| ポスター |
AI-assisted Gubra Histopathological Objective Scoring Technique (GHOST) for unbiased, fast and accurate assessment of disease severity in rodent models of NASH. |
閲覧 |
| ポスター |
Metabolic, biochemical and histological characterization of a CDAA-HFD-induced non-obese rat model of advanced NASH with progressive fibrosis. |
閲覧 |
| ポスター |
Metabolic, biochemical and histological effects of semaglutide in a CDAA-HFD-induced non-obese and biopsy-confirmed rat model of NASH with progressive fibrosis and tumor development. |
閲覧 |
| ポスター |
Metabolic, biochemical and histological effects of elafibranor in a CDAA-HFD induced non-obese rat model of advanced NASH with progressive fibrosis. |
閲覧 |
| ポスター |
Combinations of an Acetyl Coenzyme-A Carboxylase Inhibitor, FXR Agonist, and GLP-1R Agonist Inhibit Fibrosis Progression in the Rat Choline-Deficient, L-Amino-Acid–Defined, High-Fat Diet Model of Advanced Fibrosis. |
閲覧 |
